Show simple item record

dc.contributor.authorWirsing, Anna Maria
dc.contributor.authorBjerkli, Inger-Heidi
dc.contributor.authorSteigen, Sonja Eriksson
dc.contributor.authorRikardsen, Oddveig G
dc.contributor.authorNorvoll Magnussen, Synnøve
dc.contributor.authorHegge, Beate
dc.contributor.authorSeppola, Marit
dc.contributor.authorUhlin-Hansen, Lars
dc.contributor.authorHadler-Olsen, Elin Synnøve
dc.date.accessioned2021-09-13T08:57:38Z
dc.date.available2021-09-13T08:57:38Z
dc.date.issued2021-05-14
dc.description.abstractThe Pathology Atlas is an open-access database that reports the prognostic value of protein-coding transcripts in 17 cancers, including head and neck cancer. However, cancers of the various head and neck anatomical sites are specific biological entities. Thus, the aim of the present study was to validate promising prognostic markers for head and neck cancer reported in the Pathology Atlas in oral tongue squamous cell carcinoma (OTSCC). We selected three promising markers from the Pathology Atlas (<i>CALML5, CD59, LIMA1</i>), and analyzed their prognostic value in a Norwegian OTSCC cohort comprising 121 patients. We correlated target protein and mRNA expression in formalin-fixed, paraffin-embedded cancer tissue to five-year disease-specific survival (DSS) in univariate and multivariate analyses. Protein expression of <i>CALML5</i> and <i>LIMA1</i> were significantly associated with five-year DSS in the OTSCC cohort in univariate analyses (<i>p</i> = 0.016 and <i>p</i> = 0.043, respectively). In multivariate analyses, lymph node metastases, tumor differentiation, and <i>CALML5</i> were independent prognosticators. The prognostic role of the other selected markers for head and neck cancer patients identified through unbiased approaches could not be validated in our OTSCC cohort. This underlines the need for subsite-specific analyses for head and neck cancer.en_US
dc.identifier.citationWirsing, Bjerkli, Steigen, Rikardsen, Norvoll Magnussen, Hegge, Seppola, Uhlin-Hansen, Hadler-Olsen. Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort. Cancers. 2021;13(10)en_US
dc.identifier.cristinIDFRIDAID 1918440
dc.identifier.doi10.3390/cancers13102387
dc.identifier.issn2072-6694
dc.identifier.urihttps://hdl.handle.net/10037/22497
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.relation.journalCancers
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2021 The Author(s)en_US
dc.subjectVDP::Medical disciplines: 700en_US
dc.subjectVDP::Medisinske Fag: 700en_US
dc.titleValidation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohorten_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record